SUMMARY Atracurium and alcuronium have been compared during halothane anaesthesia, by measurement of the mechanical response of the adductor pollicis muscles to train-of-four stimulation and by clinical observation. Atracurium appeared significantly shorter-acting than alcuronium. However, results suggested that the action of alcuronium may not be of "medium duration ". A comparison of three indices of muscle twitch response to the train-of-four nerve stimulation, seemed to indicate that the D'/D ratio gave the best overall index of neuromuscular blockade in this study.
both measurement of mechanical muscle twitch in response to nerve stimulation, and clinical observation.
PATIENTS AND METHODS
Forty healthy women (ASA class 1), admitted for gynaecological surgery, gave informed consent for the study. All were premedicated with pethidine 1-1.5 mg kg" 1 i.m. and atropine 0.6 mg i.m. approximately 1 h before surgery. Anaesthesia was induced with thiopentone 3.5-6 mg kg" 1 i.v. and maintained with 60-66% nitrous oxide and 0.5% halothane in oxygen. Supplements of thiopentone 25 mg were given as needed during the setting up of the nerve stimulator and recording device, and whilst stable • recordings were being obtained.
The ulnar nerve was stimulated at the wrist using a Dupaco (Model 54120) nerve stimulator. Supramaximal stimuli were delivered percutaneously via 25-gauge needle electrodes. Comparison of the fourth twitch (T4) in a train of four (TOF) sequence with T4 in the TOF sequence under control conditions, was considered to provide a suitable assessment of neuromuscular blockade (Lee, Barnes and Katz, 1976) . Evoked adductor pollicis twitch tension was measured by means of a force displacement device, consisting of a spring-loaded plastic syringe, connected to a Statham P23Db pressure transducer, and record- figure 1 .
After stable control values of TOF twitch response had been obtained, patients were randomly allocated to receive either atracurium 0.5 mg kg" 1 , or alcuronium 0.25 mg kg" 1 . Intubation of the trachea was performed when 90% depression of T4 was observed, and intubating conditions were graded on the basis of five clinical observations (table I) .
Anaesthesia was maintained with 60-66% nitrous oxide and 0.5% halothane in oxygen supplemented with pethidine 20-30 mg i.v. as required. Increments of neuromuscular blocker, one-third of the loading dose, were administered when indicated by diaphragmatic activity or increased muscle tone, irrespective of the observed twitch response.
The minute volume of ventilation was adjusted to give an end-tidal carbon dioxide concentration between 4 and 5 kPa as measured on a PuritanBennett Datex infra-red end-tidal carbon dioxide monitor. In addition, samples of arterialized venous blood were taken at intervals for blood-gas analysis and for estimation of acid-base balance. At the end of each procedure, neostigmine 2.5 mg and atropine 1.2 mg i.v. were given if the recovery of the fourth twitch (T4) of TOF, was less than 75% of the control value. Immediately before extubation, a clinical assessment of the patient's neuromuscular status was made (table II) .
Observation of the patient was continued following extubation. Patients were judged fully recovered when they fulfilled the five clinical criteria indicated in table III. The time from extubation to "full recovery" was noted.
All TOF twitch response recordings were analysed, and three indices of TOF were compared to determine which demonstrated the best assessment of neuromuscular blockade ( fig. 2 ). 
FIG. 2. I-III were the three parameters of TOF compared during onset of and recovery from neuromuscular block. Parameter I formed the basis of the twitch studies in this investigation.
Statistical analysis of the results obtained was performed using the Student t test, regression of least squares, Wilcoxon rank sum test (unpaired), or the Chi squared test, where appropriate. Statistical significance was set at a probability value ofP< 0.05.
RESULTS
Both groups of patients were comparable with regard to age and weight (table IV) .
Onset of neuromuscular blockade and conditions on intubation
The onset time of neuromuscular blockade was the time from injection of the drug to 90% depression of T4. Table V shows that atracurium exhibited a more rapid rate of onset than alcuronium, but the difference between the two was not statistically significant.
The time to intubation in the atracurium group was also shorter, but not significantly so. T4 twitch height depression at intubation with alcuronium was slightly, but not significantly less than that in the atracurium group.
The clinical intubation scores awarded to the The maximum depression of T4 and the number of patients achieving 100 % neuromuscular blockade were similar in both groups (table VII) .
The T4 recovery period from maximum blockade to 10% of control twitch height was significantly shorter in the atracurium group, as were the recovery periods to 50% and 70% of control twitch height. Recovery of twitch height to 75% or-more of control within the duration of surgical anaesthesia was not observed in any patient who had received alcuronium ( fig. 3) .
Duration of anaesthesia was similar in both groups of patients, but more increments of neuromuscular blocker were required by patients who received atracurium (table VIII) . 
Reversal of neuromuscular blockade
Within the atracurium group, the time interval from the last increment of the blocker to the end of the surgical procedure, was significantly different between those patients who required neostigmine and those who did not.
All patients receiving alcuronium required neostigmine, compared with only 13 of the patients who had received atracurium. However, following the administration of neostigmine the degree of reversal of neuromuscular blockade was comparable in both groups. There was no significant difference between any group, whether or not neostigmine was required, in the time interval from reversal or cessation of anaesthesia to extubation (table IX) .
Extubation and recovery following extubation
At extubation, patients in the atracurium group who did not need neostigmine had a significantly greater degree of recovery of the T4 twitch height. The time taken to reach full "clinical" recovery, however, was similar in all patients for up to 2 h into the post-extubation period (table X) . Table XI shows the distribution of clinical extubation scores assigned to patients. There was no significant difference in the scores allocated. Within each group there was no significant correlation between the clinical extubation score and T4 recovery at extubation.
On comparison of the three indices of TOF, I was found to be the most sensitive index of neuromuscular blockade during onset, whilst III appeared to be the least sensitive. However, both I and III seemed to be equally sensitive indices of recovery from neuromuscular blockade, whereas II appeared to be the least sensitive (table XII) .
DISCUSSION
In this investigation, differences were revealed when the two neuromuscular blocking drugs were studied by measuring the adductor pollicis twitch response to train-of-four nerve stimulation, following the recommended doses.
Atracurium demonstrated a slightly, but not significantly faster onset of action. The time taken for T4 twitch height to recover to 10 % of control, reflecting the period of optimal surgical relaxation, was considerably shorter with atracurium. The rate at which T4 twitch height returned towards control values within the period of observation, was also much more rapid with atracurium, clearly illustrating its more rapid and more complete reversal characteristics. However, when using our clinical criteria, the differences were not so marked. Atracurium appeared to be shorter acting than alcuronium because, when used, increments were required more often to maintain surgical relaxation and neostigmine was required less often to antagonize neuromuscular blockade. In all other respects, the two were clinically indistinguishable. Comparable conditions for intubation were observed, and the quality of recovery following administration of neostigmine appeared to be similar.
The effects of halothane on the pharmacodynamics of non-depolarizing neuromuscular blocking drugs are related to its concentraion, but are readily reversible, and have been well documented (Baraka, 1968; Vitez, 1978; Hughes and Payne, 1979; Engbaek, 0rding and Viby-Morgensen, 1983; Stirt et al., 1983) ; it does not appear to affect the rate of onset of neuromuscular blockade of non-depolarizing blockers. This seems to be related predominantly to the dose of blocking drug (Miller et al., 1972) . Few studies have quantified the effects of low concentrations of halothane on the neuromuscular blocking actions of nondepolarizing drugs. However, it has been suggested that the use of 0.5-0.7 % halothane is preferable in studies on neuromuscular blockade, since it decreases the variability of individual response. Consequently, fewer patients need to be studied in order to detect differences (Stanski et al., 1979) .
Atracurium and alcuronium are both regarded as neuromuscular blockers with medium or intermediate durations of action. Whilst there is no generally agreed definition of medium or intermediate duration of action, definitions based on comparisons of the evoked muscle twitch response using the drug in question with those of suxamethonium and tubocurarine have been proposed (Fahey et al., 1981; Basta et al., 1982) . However, quantitative differences may occur in the evoked muscle twitch response to singletwitch, tetanic or train-of-four nerve stimulation (Hughes, 1984) . Furthermore, these differences may also arise depending on which of the indices of tetanic or train-of-four muscle twitch response are compared (Lee, Barnes and Katz, 1976) . Of the three indices of the train-of-four response we compared, the ratio of the fourth twitch in a train-of-four sequence to that in the train-of-four sequence under control conditions, appeared to give the most sensitive overall index of neuromuscular blockade.
Notwithstanding the use of low-dose halothane, the results of this comparative study of the two neuromuscular blockers would seem to suggest that, when compared with atracurium, alcuronium may not be of medium or intermediate duration.
Absolute quantitative support to this observation would require further investigation, perhaps in the absence of halothane. Nonetheless, in clinical practice alcuronium remains a very useful drug for many surgical procedures.
